Author: Shobhit Seth / Source: Investopedia U.S. pharmaceutical giant Pfizer Inc. (PFE ) announced that it has secured approval from the U.S. Food And Drug Administration (FDA) for a supplemental...
Source: Reuters Novartis on Monday won U.S. Food and Drug Administration approval for Kisqali to treat postmenopausal women with a difficult-to-treat form of breast cancer, challenging...
Author: Linda A. Johnson / Source: CTVNews The logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea on Saturday, Aug. 13, 2016. (AP / Ahn...
246,660 women will be diagnosed with breast cancer in 2016, and 40,450 women will die from the disease, suggested the American Cancer Society. More than two-thirds of all breast cancers are hormone...
The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer,...